The effect of dapagliflozin on renal function in patients with type 2 diabetes.

The effect of dapagliflozin on renal function in patients with type 2 diabetes.

Item
http://www.wikidata.org/entity/Q39984210
Effects of sodium-glucose co-transporter 2 (SGLT2) inhibition on renal function and albuminuria in patients with type 2 diabetes: a systematic review and meta-analysis.Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes.Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin.Safe and pragmatic use of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement.The use of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and hypertension: a focus on African-American populations.Update review of the safety of sodium-glucose cotransporter 2 inhibitors for the treatment of patients with type 2 diabetes mellitus.SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome.Sodium-glucose co-transporter-2 inhibitors and risk of adverse renal outcomes among patients with type 2 diabetes: A network and cumulative meta-analysis of randomized controlled trials.Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes.Dapagliflozin: potential beneficial effects in the prevention and treatment of renal and cardiovascular complications in patients with type 2 diabetes.Renal Effects of SGLT-2 Inhibitors and Other Anti-diabetic Drugs: Clinical Relevance and Potential Risks.Sodium-glucose Cotransporter-2 Inhibitors: Moving Beyond the Glycemic Treatment Goal.Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy.Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials.Systematic review and meta-analysis of the effect of SGLT-2 inhibitors on microvascular outcomes in patients with type 2 diabetes: a review protocol.Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis
P2860

The effect of dapagliflozin on renal function in patients with type 2 diabetes.

Item
http://www.wikidata.org/entity/Q39984210
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The effect of dapagliflozin on renal function in patients with type 2 diabetes.
@en
The effect of dapagliflozin on renal function in patients with type 2 diabetes.
@nl
type
label
The effect of dapagliflozin on renal function in patients with type 2 diabetes.
@en
The effect of dapagliflozin on renal function in patients with type 2 diabetes.
@nl
prefLabel
The effect of dapagliflozin on renal function in patients with type 2 diabetes.
@en
The effect of dapagliflozin on renal function in patients with type 2 diabetes.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
The effect of dapagliflozin on renal function in patients with type 2 diabetes.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921